Tuberculosis is a bacterial infection that spreads through the air. It most often affects the lungs, but can exist in any organ of the body. When a person with lung TB coughs, sneezes or spits, TB bacteria are released into the air. Another person only needs to inhale a few of these bacteria to become infected.
Second to COVID-19, TB remains one of the world’s deadliest infectious diseases. In 2018 alone, it killed close to 1.5 million people, over 95 percent of which were living in low- and middle-income countries. Every year, over 10 million people still fall ill from a disease that is both preventable and treatable. Over 10 percent of those who fall ill from the disease are co-infected with HIV, and another 10 percent are children.
The IMPAACT4TB project is implemented by a consortium whose members have exceptional experience in shaping markets, strengthening supply chain management and supporting National TB Programmes in high burden countries. The consortium will implement innovative strategies to deliver 3HP to high-risk groups in the 12 project countries, and the lessons learned along the way will be used to support scale-up globally and contribute to meeting the global End TB targets.